Capitalizing hope: the commercial development of umbilical cord blood stem cell banking

Paul A Martin; Nik Brown; Andrew Turner

doi:10.1080/14636770802077074

Capitalizing hope: the commercial development of umbilical cord blood stem cell banking

Paul A Martin, Nik Brown, Andrew Turner

Bristol Medical School (PHS)

Research output: Contribution to journal › Article (Academic Journal) › peer-review

100 Citations (Scopus)

Abstract

The creation of commercial cord blood banks rests on the promise of stem cell based regenerative medicine and marks the capitalization of human tissues within a future-oriented ?regime of hope?. This paper will present data from a survey of the international cord blood banking industry and will explore: (a) the way firms seek to commercialize cord blood as a new set of commodities; (b) the expectations and moral economy that are being constructed around this technology; and (c) how firms are acting as mediators of hope in what might be called a ?promissory bioeconomy?.

Original language	English
Pages (from-to)	127-143
Number of pages	17
Journal	New Genetics and Society
Volume	27
Issue number	2
DOIs	https://doi.org/10.1080/14636770802077074
Publication status	Published - 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1080/14636770802077074

http://dx.doi.org/10.1080/14636770802077074

Handle.net

Persistent link

Cite this

@article{7cfff194b2a149efb38ebf95bb25d949,

title = "Capitalizing hope: the commercial development of umbilical cord blood stem cell banking",

abstract = "The creation of commercial cord blood banks rests on the promise of stem cell based regenerative medicine and marks the capitalization of human tissues within a future-oriented ?regime of hope?. This paper will present data from a survey of the international cord blood banking industry and will explore: (a) the way firms seek to commercialize cord blood as a new set of commodities; (b) the expectations and moral economy that are being constructed around this technology; and (c) how firms are acting as mediators of hope in what might be called a ?promissory bioeconomy?.",

author = "Martin, {Paul A} and Nik Brown and Andrew Turner",

year = "2008",

doi = "10.1080/14636770802077074",

language = "English",

volume = "27",

pages = "127--143",

journal = "New Genetics and Society",

issn = "1463-6778",

publisher = "Routledge",

number = "2",

}

TY - JOUR

T1 - Capitalizing hope: the commercial development of umbilical cord blood stem cell banking

AU - Martin, Paul A

AU - Brown, Nik

AU - Turner, Andrew

PY - 2008

Y1 - 2008

N2 - The creation of commercial cord blood banks rests on the promise of stem cell based regenerative medicine and marks the capitalization of human tissues within a future-oriented ?regime of hope?. This paper will present data from a survey of the international cord blood banking industry and will explore: (a) the way firms seek to commercialize cord blood as a new set of commodities; (b) the expectations and moral economy that are being constructed around this technology; and (c) how firms are acting as mediators of hope in what might be called a ?promissory bioeconomy?.

AB - The creation of commercial cord blood banks rests on the promise of stem cell based regenerative medicine and marks the capitalization of human tissues within a future-oriented ?regime of hope?. This paper will present data from a survey of the international cord blood banking industry and will explore: (a) the way firms seek to commercialize cord blood as a new set of commodities; (b) the expectations and moral economy that are being constructed around this technology; and (c) how firms are acting as mediators of hope in what might be called a ?promissory bioeconomy?.

U2 - 10.1080/14636770802077074

DO - 10.1080/14636770802077074

M3 - Article (Academic Journal)

SN - 1463-6778

VL - 27

SP - 127

EP - 143

JO - New Genetics and Society

JF - New Genetics and Society

IS - 2

ER -

Capitalizing hope: the commercial development of umbilical cord blood stem cell banking

Abstract

UN SDGs

Access to Document

Handle.net

Fingerprint

Cite this